BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has reviewed its pre-IND request for a Type B review of the Company’s Covid-T™ program. “We…
health science
If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research…